Experts say women are underrepresented in clinical trials for new medications. They say this sometimes results in women having more side effects to drugs due to incorrect dosages or biological differences. Experts maintain that a greater effort must be made…
PRA Named CRO for Leukemia & Lymphoma Society Global Master Clinical Trial
Last month, the Leukemia & Lymphoma Society (LLS) and PRA Health Sciences announced their partnership in LLS’s first-of-its-kind global master clinical trial to develop new treatments for children with relapsed acute leukemia. The LLS PedAL (Pediatric Acute Leukemia) master clinical…
Moderna Fully Enrolls 30,000-Person COVID-19 Vaccine Trial, Boosts Minority Participation
Moderna has fully enrolled its late-stage coronavirus disease 2019 (COVID-19) vaccine trial by hitting its target of 30,000 participants. More than one-third of this cohort includes minority participants. The enrollment of approximately 37% of minority participants in Moderna’s Phase III…
AstraZeneca’s COVID-19 Vaccine Boosts Immune Response in Older, Younger Adults
Days after the U.S. Food and Drug Administration greenlit the restart of AstraZeneca’s Phase III COVID-19 vaccine trial, the U.K.-based company said the preventative medication boosts immune responses in older and younger adults against the novel coronavirus. Not only is…
5 Smart Ways to Maintain Regulatory Continuity and Consistency During a Global Pandemic
The impact of COVID-19 on the life sciences industry is both acute and sustained. With an unknown timeline for disruptions, organizations are planning business activities for the short-term with decisions being made weekly and even daily. In periods of rapid…
Vaxart begins dosing in trial of oral Covid-19 vaccine candidate
Biotechnology firm Vaxart has started dosing participants in a Phase I clinical trial of oral tablet Covid-19 vaccine candidate, VXA-CoV2-1. Biotechnology firm Vaxart has started dosing participants in a Phase I clinical trial of oral tablet Covid-19 vaccine candidate, VXA-CoV2-1.…
Glitches in the COVID-19 Race: Less than 24 Hours After J&J Pauses Vaccine Trial, Eli Lilly Pauses Antibody Combo Trial
Eli Lilly announced that it is pausing its clinical trial of a combination antibody against COVID-19 over safety concerns. Typically, this would be because a patient or volunteer showed a serious side effect or became sick, but the company did not…
Relief Therapeutics and NeuroRx Release Promising Data for Potential COVID-19 Treatment
Relief Therapeutics and NeuroRx released results on Tuesday from their open-label prospective study looking into RLF-100 (aviptadil) as a potential treatment for COVID-19 and respiratory failure. The topline results came from 45 patients who were assessed, 21 of whom were…
Asia-Pacific has a Record Year for Clinical Trials, according to Novotech CRO
Novotech CRO, the largest biotech CRO in Asia Pacific, says the region has had a record year for clinical trials in terms of the numbers of studies, experienced world-class sites and investigators, and patient enrollment. Novotech released its ‘Asia-Pacific Industry…
Novotech and North Asia-Based PPC Announce Strategic Partnership
Partnership Creates Region’s Largest Biotech CRO Platform to Meet Demand for Clinical Trials in Asia-Pacific SYDNEY, and SHANGHAI, 4 December 2019 – Novotech and PPC Group (PPC), two leading, Asia-Pacific contract research organisations (CROs), announced today that they have formed…
